Pages that link to "Q24656023"
Jump to navigation
Jump to search
The following pages link to Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent (Q24656023):
Displaying 50 items.
- Debio 025, a cyclophilin binding molecule, is highly efficient in clearing hepatitis C virus (HCV) replicon-containing cells when used alone or in combination with specifically targeted antiviral therapy for HCV (STAT-C) inhibitors (Q24645702) (← links)
- Suppression of coronavirus replication by cyclophilin inhibitors (Q26825245) (← links)
- Curing a viral infection by targeting the host: the example of cyclophilin inhibitors (Q26828727) (← links)
- Cyclosporine Inhibits Flavivirus Replication through Blocking the Interaction between Host Cyclophilins and Viral NS5 Protein (Q27488982) (← links)
- Essential Role of Cyclophilin A for Hepatitis C Virus Replication and Virus Production and Possible Link to Polyprotein Cleavage Kinetics (Q27489037) (← links)
- Rheumatoid arthritis in patients with HIV: management challenges (Q28075624) (← links)
- Targeting Mitochondria and Reactive Oxygen Species-Driven Pathogenesis in Diabetic Nephropathy (Q28083205) (← links)
- Characterization of the Anti-HCV Activities of the New Cyclophilin Inhibitor STG-175 (Q28551538) (← links)
- DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A (Q28748683) (← links)
- A novel anti-HIV active integrase inhibitor with a favorable in vitro cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferase metabolism profile. (Q30429621) (← links)
- Host and viral determinants of Mx2 antiretroviral activity (Q33900299) (← links)
- Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIV. (Q33962846) (← links)
- Current progress in antiviral strategies (Q34398719) (← links)
- Potent Strategy To Inhibit HIV-1 by Binding both gp120 and gp41 (Q34483474) (← links)
- Delaying reverse transcription does not increase sensitivity of HIV-1 to human TRIM5α. (Q34548171) (← links)
- Bioengineering and semisynthesis of an optimized cyclophilin inhibitor for treatment of chronic viral infection (Q35108069) (← links)
- Highly Potent Chimeric Inhibitors Targeting Two Steps of HIV Cell Entry (Q35150195) (← links)
- Identification of a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G protein (Q35451347) (← links)
- Semen of HIV-1-infected individuals: local shedding of herpesviruses and reprogrammed cytokine network (Q35623739) (← links)
- Redoxal, an inhibitor of de novo pyrimidine biosynthesis, augments APOBEC3G antiviral activity against human immunodeficiency virus type 1. (Q35682519) (← links)
- The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of Action (Q35742761) (← links)
- In Vitro Virology Profile of Tenofovir Alafenamide, a Novel Oral Prodrug of Tenofovir with Improved Antiviral Activity Compared to That of Tenofovir Disoproxil Fumarate. (Q36075908) (← links)
- Characterization of HIV-1 Resistance to Tenofovir Alafenamide In Vitro (Q36076011) (← links)
- Cross-reactive HIV-1-neutralizing activity of serum IgG from a rabbit immunized with gp41 fused to IgG1 Fc: possible role of the prolonged half-life of the immunogen (Q36102252) (← links)
- HIV-1 imposes rigidity on blood and semen cytokine networks (Q36385010) (← links)
- Identification of HIV inhibitors guided by free energy perturbation calculations (Q36708826) (← links)
- Albumin-conjugated C34 peptide HIV-1 fusion inhibitor: equipotent to C34 and T-20 in vitro with sustained activity in SCID-hu Thy/Liv mice (Q36990220) (← links)
- Correlation of naturally occurring HIV-1 resistance to DEB025 with capsid amino acid polymorphisms (Q36993953) (← links)
- Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type (Q37121420) (← links)
- Evaluation of PD 404,182 as an anti-HIV and anti-herpes simplex virus microbicide (Q37544670) (← links)
- HIV-1 uncoating: connection to nuclear entry and regulation by host proteins (Q37705207) (← links)
- Peptide Bond cis/trans Isomerases: A Biocatalysis Perspective of Conformational Dynamics in Proteins (Q37877635) (← links)
- Multiple roles of the capsid protein in the early steps of HIV-1 infection. (Q38049930) (← links)
- Revisiting dengue virus-host cell interaction: new insights into molecular and cellular virology (Q38174301) (← links)
- The role of immunophilins in viral infection (Q38274889) (← links)
- HIV-1 gag: an emerging target for antiretroviral therapy. (Q38366763) (← links)
- Synergistic Antiviral activity of Sofosbuvir and Type -I Interferons (α and β) against Zika virus (Q38693891) (← links)
- Structure-activity relationship studies of indole-based compounds as small molecule HIV-1 fusion inhibitors targeting glycoprotein 41. (Q38992313) (← links)
- Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model (Q39191241) (← links)
- The host proteins transportin SR2/TNPO3 and cyclophilin A exert opposing effects on HIV-1 uncoating. (Q39253660) (← links)
- Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsid (Q39339661) (← links)
- Suppression of feline coronavirus replication in vitro by cyclosporin A. (Q39356376) (← links)
- Potent lentiviral restriction by a synthetic feline TRIM5 cyclophilin A fusion. (Q39691970) (← links)
- An analog of camptothecin inactive against Topoisomerase I is broadly neutralizing of HIV-1 through inhibition of Vif-dependent APOBEC3G degradation. (Q40459351) (← links)
- Strain-specific differences in the impact of human TRIM5alpha, different TRIM5alpha alleles, and the inhibition of capsid-cyclophilin A interactions on the infectivity of HIV-1. (Q41824328) (← links)
- Structure-activity relationships of a novel capsid targeted inhibitor of HIV-1 replication (Q42088565) (← links)
- High level of susceptibility to human TRIM5α conferred by HIV-2 capsid sequences. (Q42264071) (← links)
- Cyclophilin inhibitors as antiviral agents (Q42284188) (← links)
- The cyclophilin inhibitor Debio 025 normalizes mitochondrial function, muscle apoptosis and ultrastructural defects in Col6a1-/- myopathic mice. (Q42545449) (← links)
- Dissociation kinetics of a binary complex in solution by protein displacement (Q44698570) (← links)